Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions		6 Months Ended
		Sep. 30, 2019	Sep. 30, 2018
Operating Activities:
Net loss		$ (59.7)	$ (160.6)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		91.2	81.1
Amortization of films and television programs and program rights		855.2	723.2
Interest on dissenting shareholders' liability		0.0	32.6
Amortization of debt financing costs		7.5	6.0
Non-cash share-based compensation		24.1	30.2
Other non-cash items		21.8	12.1
Shareholder litigation settlements	[1]	0.0	114.1
Equity interests loss		11.1	17.8
Loss on investments		0.3	37.0
Deferred income taxes (benefit)		0.6	(40.9)
Changes in operating assets and liabilities:
Accounts receivable, net and other assets		123.7	172.7
Investment in films and television programs and program rights, net		(717.1)	(697.1)
Accounts payable and accrued liabilities		(22.4)	(65.3)
Participations and residuals		(45.8)	(24.1)
Film obligations		(47.4)	(12.4)
Deferred revenue		(24.6)	43.5
Net Cash Flows Provided By Operating Activities		218.5	269.9
Investing Activities:
Investment in equity method investees		(4.9)	(22.0)
Business acquisitions, net of cash acquired of $5.5 (see Note 2)		0.0	(77.3)
Capital expenditures		(16.9)	(21.6)
Net Cash Flows Used In Investing Activities		(21.8)	(120.9)
Financing Activities:
Debt - borrowings		302.0	2,069.5
Debt - repayments		(328.5)	(2,144.8)
Production loans - borrowings		51.8	154.5
Production loans - repayments		(168.2)	(189.7)
Dividends paid		0.0	(38.2)
Distributions to noncontrolling interest		(3.6)	(1.5)
Exercise of stock options		0.5	1.8
Tax withholding required on equity awards		(1.8)	(4.0)
Net Cash Flows Used In Financing Activities		(147.8)	(152.4)
Net Change In Cash, Cash Equivalents and Restricted Cash		48.9	(3.4)
Foreign Exchange Effects on Cash, Cash Equivalents and Restricted Cash		(0.6)	(2.4)
Cash, Cash Equivalents and Restricted Cash - Beginning Of Period		184.3	378.1
Cash, Cash Equivalents and Restricted Cash - End Of Period		$ 232.6	$ 372.3

[1] Shareholder litigation settlements of $114.1 million in the three and six months ended September 30, 2018 includes the following: (i) $54.8 million for the net expense recorded for the settlement of the Fiduciary Litigation (representing the settlement amount of $92.5 million, net of aggregate insurance reimbursement of $37.8 million (see Note 16) and (ii) $59.3 million related to the Appraisal Litigation, representing the amount by which the settlement amount of approximately $964 million exceeded the previously accrued (at date of acquisition) dissenting shareholders' liability plus interest through the date agreed in the settlement.